0000899243-20-030329.txt : 20201103 0000899243-20-030329.hdr.sgml : 20201103 20201103200825 ACCESSION NUMBER: 0000899243-20-030329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201103 FILED AS OF DATE: 20201103 DATE AS OF CHANGE: 20201103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sommadossi Jean-Pierre CENTRAL INDEX KEY: 0001296995 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39661 FILM NUMBER: 201284924 MAIL ADDRESS: STREET 1: C/O IDENIX PHARMACEUTICALS, INC. STREET 2: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-03 0 0001593899 Atea Pharmaceuticals, Inc. AVIR 0001296995 Sommadossi Jean-Pierre 125 SUMMER STREET BOSTON MA 02110 1 1 0 0 President, CEO, and Chairman Common Stock 2020-11-03 4 C 0 750000 A 5925000 I Held by JPM Partners LLC Series A Convertible Preferred Stock 2020-11-03 4 C 0 750000 D Common Stock 750000 0 I Held by JPM Partners LLC The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. /s/ Andrea Corcoran, attorney-in-fact for Jean-Pierre Sommadossi 2020-11-03